Skip to content

Clinical Study on Electroacupuncture on Insomnia of Breast Cancer Survivors by PPSG

Clinical Study on Electroacupuncture on Insomnia of Breast Cancer Survivors by PPSG

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058962
Enrollment
Unknown
Registered
2022-04-20
Start date
2022-06-01
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia of Breast Cancer Survivors

Interventions

Experimental group:acupuncture
Control group:sham acupuncture

Sponsors

Jiangsu Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 70 years; 2. Women diagnosed with primary breast cancer for the first time; 3. The stage of breast cancer was ?-?; 4. Expected survival time >=6 months; 5. Insomnia symptoms >=1 month after diagnosis of breast cancer; 6. ISI score >=11 points; 7. Stop any radiotherapy, chemotherapy, hormone therapy and immunotherapy for more than 1 month, and the condition is stable; 8. Voluntarily participate in this experiment and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. For insomnia caused by physical pain, Numerical Rating Scale (NRS) score >=4; 2. HADS anxiety or depression score >=11; 3. Addiction to caffeine, alcohol or psychotropic drugs; 4. There are serious diseases such as cardiovascular and cerebrovascular, liver and kidney insufficiency, hematopoietic system and metabolism; 5. At baseline, patients with other sleep disorders such as obstructive sleep apnea and restless leg syndrome were diagnosed with PPSG; 6. Patients who are pregnant, lactating or preparing for pregnancy; 7. Patients who are also participating in other trials; 8. Related interventions to stop insomnia (including Chinese medicine, acupuncture, massage, Western medicine) <=2 weeks.

Design outcomes

Primary

MeasureTime frame
Sleep parameter;Insomnia Severity Index (ISI);

Secondary

MeasureTime frame
Assessment of Cancer Therapeutic Function - Breast Cancer (FACT-B);Hospital Anxiety and Depression Scale;

Countries

China

Contacts

Public ContactLiu Chengyong

Jiangsu Provincial Hospital of Traditional Chinese Medicine

1215263675@qq.com+86 13228128978

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026